Australia markets closed

Instil Bio, Inc. (TIL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.60+0.21 (+2.02%)
At close: 04:00PM EDT
10.51 -0.09 (-0.85%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 68.94M
Enterprise value 4.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.03

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-17.57%
S&P500 52-week change 322.36%
52-week high 314.00
52-week low 36.08
50-day moving average 311.39
200-day moving average 39.47

Share statistics

Avg vol (3-month) 315.07k
Avg vol (10-day) 311.03k
Shares outstanding 56.5M
Implied shares outstanding 66.5M
Float 83.06M
% held by insiders 16.84%
% held by institutions 165.96%
Shares short (15 Apr 2024) 49.3k
Short ratio (15 Apr 2024) 40.77
Short % of float (15 Apr 2024) 40.30%
Short % of shares outstanding (15 Apr 2024) 40.14%
Shares short (prior month 15 Mar 2024) 415.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 308 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-14.01%
Return on equity (ttm)-52.96%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -85.78M
Net income avi to common (ttm)-156.09M
Diluted EPS (ttm)-24.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)151.41M
Total cash per share (mrq)23.28
Total debt (mrq)86.05M
Total debt/equity (mrq)38.11%
Current ratio (mrq)15.23
Book value per share (mrq)34.72

Cash flow statement

Operating cash flow (ttm)-82.03M
Levered free cash flow (ttm)-82.27M